Experts Link Trump-era Public Health Funding Cuts to Slower Cyclospora Outbreak Response
Public-health scholars say reductions in CDC staffing and FDA resources under the Trump administration have hampered surveillance and communication during the current cyclosporiasis outbreak, though officials claim the response remains robust.
The United States is confronting a cyclosporiasis outbreak that has reached more than 1,600 confirmed cases, while public-health experts warn that recent cuts to federal health programs have limited the speed and scope of the response.
A spokesperson for the U.S. Department of Health and Human Services told HuffPost that the administration has maintained a "robust response" and is working with state health departments to identify sources and inform the public. The agency added that the FDA and CDC are using all available tools to address the outbreak.
Jennifer Nuzzo, director of the Pandemic Center at Brown University, noted that a 2025 change to the CDC’s FoodNet program removed cyclospora from mandatory monitoring, reducing focus on the parasite and signaling a lower priority across the system. She said the lack of surveillance made it harder to detect and contain outbreaks early.
Jessica Steier, founder and CEO of Unbiased Science, said funding reductions likely delayed the understanding of the outbreak’s scope and public communication, while Elisabeth Marnik of The Evidence Collective said staffing cuts have negatively impacted the overall response. Both emphasized that states rely on CDC alerts to guide local investigations, but about 80% of CDC leadership positions are vacant.
The CDC issued a health alert in mid-July reporting 1,645 confirmed cases and 5,100 pending analyses, yet discrepancies between federal and state numbers created public confusion, according to Steier. Marnik called for greater transparency and clearer messaging, especially after a false-positive lettuce test from Taylor Farms was later corrected.
Steier also highlighted long-standing resource constraints at the FDA, noting a 20% staff loss during the second Trump term and the disbanding of key advisory committees. She said a 2022 Food Traceability Rule, intended to improve supply-chain records, has been delayed until at least 2028, further limiting oversight.
Overall, the experts argue that while the cuts did not cause the contamination, they have weakened the public-health infrastructure, making the United States less prepared for future infectious-disease threats.